BRWA
ARNA

B. Riley Wealth Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

B. Riley Wealth Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,600
Closed -$24K – 566
2017
Q1 		$24K Hold
1,600
– – ﹤0.01% 512
2016
Q4 		$23K Sell
1,600
-500
-24% -$7.74K ﹤0.01% 529
2016
Q3 		$37K Buy
2,100
+500
+31% +$8.29K 0.01% 606
2016
Q2 		$28K Hold
1,600
– – 0.01% 605
2016
Q1 		$32K Sell
1,600
-100
-6% -$1.6K 0.01% 545
2015
Q4 		$33K Sell
1,700
-20
-1% -$408 0.01% 550
2015
Q3 		$33K Sell
1,720
-170
-9% -$5.77K 0.01% 540
2015
Q2 		$88K Buy
1,890
+390
+26% +$16.9K 0.02% 501
2015
Q1 		$66K Buy
1,500
+1,090
+266% +$50.7K 0.02% 520
2014
Q4 		$14 Sell
410
-650
-61% -$26.4K ﹤0.01% 2715
2014
Q3 		$44K Buy
1,060
+213
+25% +$9.51K 0.01% 608
2014
Q2 		$49.6K Sell
847
-653
-44% -$41.1K 0.01% 1037
2014
Q1 		$14K Buy
+1,500
New +$99.5K ﹤0.01% 751

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

B. Riley Wealth Advisors's ARNA Position: Q2 2017 in Review

B. Riley Wealth Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2017, closing a stake of 1,600 shares — an estimated $24K sold.

B. Riley Wealth Advisors first reported a position in ARNA in Q1 2014 and held it in 13 quarters. The position peaked at $88K in Q2 2015. 102 funds tracked by Wall St. Rank hold ARNA as of Q2 2017.

  • B. Riley Wealth Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q2 2017 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 1,600 Arena Pharmaceuticals Inc shares in Q2 2017, an estimated $24K.
  • B. Riley Wealth Advisors first reported a position in Arena Pharmaceuticals Inc in Q1 2014 and held it in 13 quarters.
  • B. Riley Wealth Advisors's Arena Pharmaceuticals Inc position peaked at $88K in Q2 2015.
  • 102 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2017.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2017, filed 15 Aug 2017.